Giammaria Giuliani
$1.9B
Born
Feb 20, 1978
Age
48
Source of Wealth
Pharmaceuticals
Residence
Montagnola,
Citizenship
Switzerland
Marital Status
Married
Children
0
Education
- Giammaria Giuliani is a healthcare investor who owns a 5% stake in Royalty Pharma, the world's largest acquirer of pharmaceutical royalties.
- Royalty Pharma went public in 2020 and has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica and Xtandi.
- Giammaria and his brother Mario also own stakes in Swiss investment company HBM Healthcare Investments and a number of biotech firms in the U.S.
- The brothers share ownership of their family's pharmaceutical company, Giuliani, founded by their great-grandfather Germano in Milan, Italy in 1889.
- They also own real estate investments in Europe and the U.S., including a planned commercial and residential project on a maritime platform in Monaco.
- The family company's best-known product is Amaro Giuliani, a herbal digestive remedy invented by Germano, a chemist, when he bought a pharmacy in Milan in 1889.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|